Coriell Life Sciences
Camden, US · Founded 2013 · Delaware corporation
Founders & leadership
SM
Scott MegillExecutive
Board
SA
Stephen AndrioleBoard director
MF
Michael F. ChristmanBoard director
Reported raises · per SEC filings
Form D private placements$10.1M disclosed across 2 rounds · 2016–2019
▶$9.5MraisedMay 2019 · 4 investors · BiotechnologyRule 506(b)
▶$9.5MraisedMay 2019 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Scott MegillExecutive Officer, Director
- Dr. Stephen AndrioleDirector
- Peter DriscollDirector
- Offering amount
- $10M
- Amount sold
- $9.5M
- First sale
- Apr 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$605KraisedJul 2016 · 9 investors · BiotechnologyRule 506(b)
▶$605KraisedJul 2016 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Scott MegillExecutive Officer, Director
- Stephen AndrioleDirector
- Michael F. ChristmanDirector
- Offering amount
- $1.5M
- Amount sold
- $605K
- First sale
- Jun 2016
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Coriell Life Sciences raised?
- Coriell Life Sciences has disclosed $10.1M raised across 2 rounds.
- Where is Coriell Life Sciences headquartered?
- Coriell Life Sciences is headquartered in Camden, US.